b.fonseca

TL2 · Malmö

Contributes reviews on supplier material. Based in Malmö.

Joined 15 October 2024 · last posted just now

79 posts, newest first. Showing up to 150.

I joined for one answer and stayed for a year — what changed my mind Replied, post #115 · Start Here › Welcome · 28 Jul 2026 · 21 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
Coming back to: Storing in the door of the fridge is worse than you think Replied, post #7 · Practice › Storage & stability · 27 Jul 2026 · 2 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
Revisiting: How this community labels and discusses unrefereed work Replied, post #32 · Evidence › Preprints · 23 Jul 2026 · 22 likes Post #31 describes the usual case. This is about the unusual one. Where I have landed on community labels, having got it wrong once in public: the direction is clear,…
Submitting a sample: the process end to end Replied, post #101 · Sourcing › Independent verification · 22 Jul 2026 · 4 likes The documentation on submitting a sample is better than this thread and I say that as someone who has posted in the thread.
Common supplements people ask about, assessed one at a time Replied, post #65 · Practice › Interactions · 18 Jul 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
What to bring: records that a clinician can actually use — a second dataset Replied, post #46 · Clinical › Prescriber conversations · 17 Jul 2026 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #20 · Analytics › Home & field testing · 13 Jul 2026 · 14 likes Taking post #17 at face value and following it one step further. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #44 · Analytics › Home & field testing · 2 Jul 2026 · 1 like Distinguishing three things in the home kit substitute discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Follow-up: Reconciling a label claim with a content assay Replied, post #28 · Analytics › COA interpretation · 28 Jun 2026 · 22 likes Narrowing post #25, because the general version has more than one answer. Two claims get bundled together under Reconciling a label claim and they need separating. The…
Ultrasound and skinfolds: operator dependence in practice Replied, post #25 · Outcomes › Body composition · 21 Jun 2026 · 1 like Post #23 put the caveat in the right place and I want to underline it. A note on how ultrasound and skinfolds gets discussed rather than on ultrasound and skinfolds…
An appeal that succeeded, with the letter structure — the long version Replied, post #90 · Access › Insurance & coverage · 13 Jun 2026 · 9 likes Picking up post #89: that is the part I would want checked first. My understanding of appeal is a few years old and may have been superseded. If it has been, I would…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #73 · Practice › Administration · 12 Jun 2026 · 25 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #2 · Access › Insurance & coverage · 31 May 2026 · 10 likes Adding a data point of agreement rather than a data point.
CJC-1295 with and without DAC: what the modification does Replied, post #59 · Compounds › Secretagogues & GH axis · 17 May 2026 · 6 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #26 · Analytics › Mass spectrometry · 11 May 2026 · 7 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Second pass at: Metformin co-administration and additive GI effects Replied, post #100 · Practice › Interactions · 7 May 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
The "under review" status pill and when a moderator applies it Replied, post #81 · Evidence › Preprints · 18 Apr 2026 · 0 likes Post #80 is right about the mechanism and I think understates the practical bit. Preprints for speed: some important preliminary findings are posted as preprints to…
The "under review" status pill and when a moderator applies it Replied, post #62 · Evidence › Preprints · 8 Apr 2026 · 3 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. I would…
Conditions that change the calculus rather than forbidding it Replied, post #3 · Safety › Contraindications · 13 Mar 2026 · 4 likes Pregnancy appears in the labelling for this class and the position is stated explicitly rather than left to inference.
Contributing data without breaching anyone's privacy Replied, post #47 · Data & Tools › Datasets · 5 Mar 2026 · 0 likes Post #44 describes the usual case. This is about the unusual one. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Started this topic · Compounds › Oral incretins · 3 Mar 2026 · 6 likes Posting this under the heading it deserves: Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Everything below is what sits…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #14 · Outcomes › Progress reports · 2 Mar 2026 · 15 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not.
The headache that turns out to be dehydration — the long version Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 22 Feb 2026 · 6 likes Where a laboratory result exists, quoting it with the reference interval makes the discussion tractable. Without it the thread is guesswork. Two sources, same…
[2026 update] What a purity-only report leaves out Replied, post #19 · Sourcing › Independent verification · 8 Feb 2026 · 6 likes Small correction to my own earlier position on purity-only. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #19 · Evidence › Trials · 31 Jan 2026 · 1 like Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Preprint servers and what screening they do Replied, post #32 · Evidence › Preprints · 23 Jan 2026 · 0 likes Post #28 describes the usual case. This is about the unusual one. Practical experience of preprint servers, offered as one case with the conditions stated, not as a…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #43 · Access › International · 6 Jan 2026 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Second pass at: The topic list is dense — is that deliberate? Replied, post #36 · Meta › Site feedback · 5 Jan 2026 · 0 likes Post #35 describes the usual case. This is about the unusual one. I would keep topic list and the decision it usually gets used for separate in this thread. They are…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #120 · Compounds › Oral incretins · 31 Dec 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
Reading SURMOUNT-1 without the press release Replied, post #119 · Compounds › Tirzepatide · 29 Dec 2025 · 30 likes Adding the measurement that post #116 says would settle it. Counterpoint on reading SURMOUNT-1 without the press, offered without confidence: the same observation is…
Where impurities in solid-phase peptide synthesis come from Replied, post #28 · Analytics › Impurities & related substances · 20 Dec 2025 · 0 likes Post #25 answers the question as asked. The question underneath it is different. I would call the community position on impurities in solid-phase peptide synthesis…
Substitution between formats during a shortage Replied, post #118 · Access › Shortages · 17 Dec 2025 · 8 likes I had written a reply contradicting post #116 and deleted it. Here is what survived. Regional differences during a shortage are large, and a supply position in one…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #88 · Compounds › Tirzepatide · 12 Dec 2025 · 12 likes Coming back to post #84, because the follow-up matters more than the original answer. Gastrointestinal effects were comparable in character to the GLP-1 monoagonists…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #47 · Practice › Reconstitution · 24 Nov 2025 · 7 likes Everything in post #46 holds. The case it does not cover is the one I have. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
A widely repeated interaction claim that turns out to be unsupported Replied, post #6 · Practice › Interactions · 19 Nov 2025 · 15 likes Worth separating two things that post #4 runs together. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #33 · Clinical › Special populations · 17 Nov 2025 · 21 likes Checked the older adults claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
The anatomy of a question that gets answered within an hour — the long version Replied, post #97 · Start Here › How to Ask · 14 Nov 2025 · 8 likes Picking up post #94: that is the part I would want checked first. Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can…
Where to report an adverse event officially, by region — a second dataset Replied, post #105 · Safety › Adverse events · 8 Nov 2025 · 0 likes Where I part company with post #103, and it is a narrow parting. Injection-site reactions that spread over a day or come with systemic symptoms are a different…
Guidelines revision: what changed and why — one year on Replied, post #32 · Meta › Announcements · 4 Nov 2025 · 18 likes Reading the changed pages: the diff is smaller than the announcement implies, which is reassuring rather than disappointing. A large change to a documentation page…
High-resolution MS on aggregates and what it can see Replied, post #109 · Analytics › Mass spectrometry · 2 Nov 2025 · 11 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Follow-up: What a seizure notice actually says Replied, post #33 · Sourcing › Logistics · 27 Oct 2025 · 11 likes I read post #31 twice before replying, because I had assumed the opposite. Anyone deciding whether a delay is a problem should ask what would change if they waited…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #104 · Lounge › Off topic · 18 Oct 2025 · 0 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #70 · Lounge › Off topic · 2 Oct 2025 · 31 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #88 · Analytics › HPLC & UHPLC · 29 Sep 2025 · 9 likes Adding a small correction to the Resolution and tailing factor summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
Documentation that appears only after payment Replied, post #33 · Sourcing › Red flags · 25 Sep 2025 · 9 likes Nobody has said the unglamorous part of documentation yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #41 · Compounds › Secretagogues & GH axis · 29 Aug 2025 · 2 likes Taking post #40 at face value and following it one step further. Adding a small correction to the reading a rodent study summary above rather than a disagreement with…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #21 · Analytics › COA interpretation · 17 Aug 2025 · 31 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #159 · Compounds › Tirzepatide · 8 Aug 2025 · 25 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
Travel coolers and how long they really hold Replied, post #48 · Devices › Cold chain · 4 Aug 2025 · 0 likes Two things can be true about travel coolers at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #37 · Practice › Reconstitution · 29 Jul 2025 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
Coming back to: When "no data" is the complete and final answer Replied, post #49 · Compounds › Other compounds · 18 Jul 2025 · 7 likes Post #48 put the caveat in the right place and I want to underline it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Repeatability versus intermediate precision Replied, post #55 · Analytics › Method validation · 24 Jun 2025 · 7 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
How this community escalates rather than diagnoses Started this topic · Safety › Adverse events · 17 Jun 2025 · 32 likes How this community escalates rather than diagnoses — that is the question, and I have not found it answered plainly anywhere I have looked. Community escalates, and…
Coming back to: Getting a referral rather than a refusal Replied, post #70 · Clinical › Prescriber conversations · 14 Jun 2025 · 5 likes I had written a reply contradicting post #68 and deleted it. Here is what survived. If you have been doing something the prescriber does not know about, saying so is…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #28 · Evidence › Journal club · 11 Jun 2025 · 0 likes Adding the measurement that post #25 says would settle it. My position on STEP 4 is current rather than settled. I have revised it once already and I expect to again,…
A ten-fold dose error caught before injection Replied, post #47 · Devices › Syringes & needles · 10 Jun 2025 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
An orphaned page with no inbound links Replied, post #48 · Meta › Wiki maintenance · 2 Jun 2025 · 30 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #3 · Nutrition & Training › Protein & intake · 1 Jun 2025 · 21 likes Coming back to the opening post, because the follow-up matters more than the original answer. Adding a small correction to the Tracking intake summary above rather than…
Units, standards, and other things that quietly hold the world together Replied, post #21 · Lounge › Off topic · 16 Apr 2025 · 0 likes Since we are being unserious: the number of times I have watched a thread turn on somebody quietly asking "at what wavelength" is now genuinely funny. That distinction…
Certificates issued by the seller versus by a laboratory Replied, post #38 · Analytics › COA interpretation · 10 Apr 2025 · 9 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Deamidation and the close-eluting pair it produces Replied, post #11 · Analytics › Impurities & related substances · 19 Mar 2025 · 27 likes Taking post #10 at face value and following it one step further. Taking deamidation seriously for a moment rather than deflecting: the honest position is that the…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #29 · Compounds › Other compounds · 8 Mar 2025 · 3 likes Worth separating two things that post #26 runs together. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds…
Counter-ion form: the field almost nobody reports — one year on Replied, post #7 · Analytics › COA interpretation · 17 Feb 2025 · 10 likes Post #6 answers the question as asked. The question underneath it is different. If someone has run Counter-ion form properly I would rather read that than my own…
Coming back to: An 18-month record including the parts that went badly Replied, post #18 · Outcomes › Progress reports · 17 Feb 2025 · 0 likes Having read the whole 18-month record thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
Distinguishing a deletion sequence by mass alone Replied, post #89 · Analytics › Mass spectrometry · 15 Feb 2025 · 0 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #91 · Analytics › COA interpretation · 31 Jan 2025 · 17 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #25 · Practice › Dosing & titration · 18 Jan 2025 · 11 likes Answering the question post #21 raises rather than the one it answers. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…
Recovery when intake is low: what to cut first Replied, post #21 · Nutrition & Training › Resistance training · 10 Jan 2025 · 0 likes Worth separating two things that post #17 runs together. Two things can be true about recovery at once: the mechanism is plausible and the evidence for the size of the…
Talking to a therapist about this specifically — does this still hold? Replied, post #3 · Wellbeing › Mental health · 6 Jan 2025 · 7 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #22 · Compounds › Oral incretins · 5 Jan 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
UK access routes, dated and sourced — a second dataset Replied, post #15 · Regional › UK & Ireland · 12 Dec 2024 · 10 likes Right — I had this wrong and I am glad to have read it before it mattered.
Why I ask for the gradient before I discuss the number Replied, post #39 · Analytics › HPLC & UHPLC · 26 Nov 2024 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
[2026 update] New subcategory: rationale and scope Replied, post #19 · Meta › Announcements · 23 Nov 2024 · 29 likes Two things can be true about New subcategory at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
Why "any advice?" is the least effective ending for a post Replied, post #54 · Start Here › How to Ask · 20 Nov 2024 · 0 likes I read post #50 twice before replying, because I had assumed the opposite. Disagreement-style questions: "I read this and it contradicts what I heard here, which is…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #23 · Compounds › Retatrutide · 7 Sep 2024 · 0 likes Confirming post #22 from a second method, which matters more than confirming it from a second person. Retatrutide is investigational. Anything obtained outside a trial…
Circumference measurements as a poor man's composition estimate Replied, post #96 · Outcomes › Body composition · 25 Aug 2024 · 0 likes That is a cleaner way of putting what I was circling around.
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #2 · Compounds › Oral incretins · 24 Aug 2024 · 25 likes A definition problem is doing most of the work in this orforglipron discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
The C-cell question: rodent findings and their human context — what changed since Replied, post #19 · Compounds › Semaglutide · 24 Aug 2024 · 30 likes Post #16 answers the question as asked. The question underneath it is different. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes…
Assessing a warm arrival: the decision process — one year on Replied, post #17 · Sourcing › Logistics · 28 May 2024 · 21 likes Post #14 answers the question as asked. The question underneath it is different. The number people quote for Assessing a warm arrival is a central estimate presented…